The new report by Expert Market Research titled, ‘Global Non-Invasive Prenatal Testing (NIPT) Market Share, Report and Forecast 2023-2028’, gives an in-depth analysis of the global non-invasive prenatal testing (NIPT) market, assessing the market based on its segments like products and services, methods, applications, end-users, and major regions.
The report tracks the latest trends in the industry and studies their impact on the overall market. It also assesses the market dynamics, covering the key demand and price indicators, along with analysing the market based on the SWOT and Porter’s Five Forces models.
Get a Free Sample Report with Table of Contents: https://www.expertmarketresearch.com/reports/non-invasive-prenatal-testing-nipt-market/requestsample
The key highlights of the report include:
Market Overview (2018-2028)
- Historical Market Size (2022): USD 1.74 Billion
- Forecast CAGR (2023-2028): 14.30%
- Forecast Market Size (2028): USD 3.88 Billion
The increasing incidences of chromosomal abnormalities, coupled with growing maternal age, is driving the market growth. Women with high and average risk pregnancies held the largest share of these tests. Increasing awareness regarding the prevention of chromosomal anomalies, like down syndrome, has also contributed to this segment.
Factors like improving technology, alliances and partnerships among key market players, improved chemistry, and bioinformatics analysis, quick adoption of next-generation sequencing, new product launches, government initiative, and established healthcare infrastructure are fuelling the market growth. Introduction of NIPT, for the detection of down syndrome in routine prenatal care has resulted in an increase in the demand for these technologies and is being adopted by many developing countries.
Industry Definition and Major Segments
Non-invasive prenatal testing (NIPT), also known as non-invasive prenatal screening (NIPS), is a sensitive test done in the first trimester to determine the risk of a foetus being born with certain genetic abnormalities. It is mostly done to check the possibilities of down syndrome. During pregnancy, some of the baby’s DNA passes into the mother’s bloodstream. It analyses the genetic information contained in this DNA to determine the number of abnormalities.
Read Full Report with Table of Contents: https://www.expertmarketresearch.com/reports/non-invasive-prenatal-testing-nipt-market
By products and services, the market is divided into:
The various types of methods of non-invasive prenatal testing (NIPT) include:
- Ultrasound Detection
- Biochemical Screening Tests
- Cell-Free DNA in Maternal Plasma Tests
The major applications of the product are:
- Microdeletion Syndrome
On the basis of end users, the industry is divided into:
- Diagnostic Laboratories
The global markets of logistics automation can be divided into:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
Advantages of non-invasive prenatal tests over other prenatal tests, like its non-invasive nature, better accuracy, and short duration of the procedure, are anticipated to fuel the growth of the market during the forecast period. The outbreak of COVID-19 has positively impacted the growth. There is tremendous pressure on hospitals to adhere to COVID-19 patients, so hospitals and diagnostic centres are providing non-invasive prenatal testing (NIPT) services as it offers high accuracy screening with low risk of infection, as compared to other invasive procedures, like Amniocentesis and chorionic villus sampling (CVS), both of them require hospital admission that can result in exposure of both doctors and patients to the risk of the COVID infection.
Key Market Players
The major players in the market are Illumina, Inc., Thermo Fisher Scientific Corporation, PerkinElmer, Inc., Agilent Technologies, Inc., and F. Hoffmann-La Roche AG, among others. The report covers the market shares, capacities, plant turnarounds, expansions, investments and mergers and acquisitions, among other latest developments of these market players.
Expert Market Research (EMR) is leading market research company with clients across the globe. Through comprehensive data collection and skillful analysis and interpretation of data, the company offers its clients extensive, latest, and actionable market intelligence which enables them to make informed and intelligent decisions and strengthen their position in the market. The clientele ranges from Fortune 1000 companies to small and medium scale enterprises.
EMR customises syndicated reports according to clients’ requirements and expectations. The company is active across over 15 prominent industry domains, including food and beverages, chemicals and materials, technology and media, consumer goods, packaging, agriculture, and pharmaceuticals, among others.
Over 3000 EMR consultants and more than 100 analysts work very hard to ensure that clients get only the most updated, relevant, accurate and actionable industry intelligence so that they may formulate informed, effective and intelligent business strategies and ensure their leadership in the market.
Company Name: Claight Corporation
Contact Person: Tom Anderson, Corporate Sales Specialist – U.S.A.
Toll Free Number: +1-415-325-5166 | +44-702-402-5790
Address: 30 North Gould Street, Sheridan, WY 82801, USA